Study Links Severity of Obesity to Elevated Risk for BE and Esophageal Cancer

The risk of developing BE and EAC increases with severity of obesity, according to a new study presented at DDW ...

MAY 6, 2025

Liquid Biopsy Promising for Early Detection of BE and EAC

A newly developed liquid biopsy assay accurately identified patients with Barrett’s esophagus and esophageal ...

APRIL 21, 2025

FDA Approves Opdivo Qvantig for Subcutaneous Injection

The FDA approved nivolumab plus hyaluronidase (Opdivo Qvantig, Bristol Myers Squibb) for an array of GI cancers.

JANUARY 8, 2025

BE Indefinite for Dysplasia Requires Close Follow-up in Year After Diagnosis

Management of patients with Barrett’s esophagus who have tissue that is indefinite for dysplasia hasn’t ...

DECEMBER 18, 2024

Epigenetic Prognostic Assay Aims for Risk Stratification in Barrett’s Esophagus

An epigenetic prognostic assay may help personalize Barrett’s esophagus monitoring, according to a new ...

NOVEMBER 13, 2024

BE Indefinite for Dysplasia Requires Close Follow-up in Year After Diagnosis

Management of Barrett’s esophagus patients who have tissue that is indefinite for dysplasia hasn’t ...

OCTOBER 23, 2024

AGA Issues Updated Guideline on Endoscopic Eradication Therapy for BE

The AGA recently published a clinical practice guideline on endoscopic eradication therapy for Barrett’s ...

OCTOBER 1, 2024

Expert Picks From DDW 2024, Part 2

In this installment of Expert Picks from DDW 2024, Michelle A. Anderson, MD, MSc, discusses four research picks ...

SEPTEMBER 13, 2024

Chemotherapy Before and After Surgery Benefits Patients With Resectable Esophageal Cancer

Chemotherapy before and after surgery for locally advanced esophageal adenocarcinoma improved survival relative to ...

AUGUST 7, 2024

Barrett’s Esophagus: Guideline Interpretation and Application to Management

This review provides an update on the recently published guidelines from the ACG and AGA on the diagnosis and ...

AUGUST 1, 2024

RFA Associated With Lower Risk of EAC in BE Patients

Radiofrequency ablation treatment is effective in reducing the likelihood of progression to cancer, according to ...

MAY 19, 2024

Nonerosive GERD Did Not Increase Esophageal Ca Risk in Nordic Nations

Patients diagnosed with nonerosive gastroesophageal reflux disease did not have a higher incidence of esophageal ...

DECEMBER 20, 2023